Enfusion, Inc. (ENFN)
NYSE: ENFN · Real-Time Price · USD
11.10
-0.04 (-0.36%)
At close: Mar 28, 2025, 4:00 PM
11.14
+0.04 (0.34%)
After-hours: Mar 28, 2025, 8:00 PM EDT

Enfusion Statistics

Total Valuation

Enfusion has a market cap or net worth of $1.43 billion. The enterprise value is $1.40 billion.

Market Cap 1.43B
Enterprise Value 1.40B

Important Dates

The last earnings date was Monday, March 3, 2025, after market close.

Earnings Date Mar 3, 2025
Ex-Dividend Date n/a

Share Statistics

Enfusion has 129.00 million shares outstanding. The number of shares has increased by 0.09% in one year.

Current Share Class 94.80M
Shares Outstanding 129.00M
Shares Change (YoY) +0.09%
Shares Change (QoQ) +0.45%
Owned by Insiders (%) 2.14%
Owned by Institutions (%) 51.45%
Float 46.32M

Valuation Ratios

The trailing PE ratio is 507.23 and the forward PE ratio is 37.93.

PE Ratio 507.23
Forward PE 37.93
PS Ratio 5.07
Forward PS 5.94
PB Ratio 14.35
P/TBV Ratio 19.56
P/FCF Ratio 46.12
P/OCF Ratio 41.29
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 109.98, with an EV/FCF ratio of 45.02.

EV / Earnings 495.13
EV / Sales 6.93
EV / EBITDA 109.98
EV / EBIT 227.09
EV / FCF 45.02

Financial Position

The company has a current ratio of 3.42, with a Debt / Equity ratio of 0.20.

Current Ratio 3.42
Quick Ratio 3.16
Debt / Equity 0.20
Debt / EBITDA 0.95
Debt / FCF 0.65
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is 4.42% and return on invested capital (ROIC) is 3.62%.

Return on Equity (ROE) 4.42%
Return on Assets (ROA) 3.05%
Return on Invested Capital (ROIC) 3.62%
Return on Capital Employed (ROCE) 5.31%
Revenue Per Employee $176,388
Profits Per Employee $2,470
Employee Count 1,143
Asset Turnover 1.60
Inventory Turnover n/a

Taxes

In the past 12 months, Enfusion has paid $3.47 million in taxes.

Income Tax 3.47M
Effective Tax Rate 47.02%

Stock Price Statistics

The stock price has increased by +20.26% in the last 52 weeks. The beta is 0.95, so Enfusion's price volatility has been similar to the market average.

Beta (5Y) 0.95
52-Week Price Change +20.26%
50-Day Moving Average 11.18
200-Day Moving Average 9.66
Relative Strength Index (RSI) 46.55
Average Volume (20 Days) 904,567

Short Selling Information

The latest short interest is 1.01 million, so 0.78% of the outstanding shares have been sold short.

Short Interest 1.01M
Short Previous Month 1.04M
Short % of Shares Out 0.78%
Short % of Float 2.18%
Short Ratio (days to cover) 0.87

Income Statement

In the last 12 months, Enfusion had revenue of $201.61 million and earned $2.82 million in profits. Earnings per share was $0.03.

Revenue 201.61M
Gross Profit 136.74M
Operating Income 6.16M
Pretax Income 5.67M
Net Income 2.82M
EBITDA 12.71M
EBIT 6.16M
Earnings Per Share (EPS) $0.03
Full Income Statement

Balance Sheet

The company has $54.48 million in cash and $20.31 million in debt, giving a net cash position of $34.17 million or $0.26 per share.

Cash & Cash Equivalents 54.48M
Total Debt 20.31M
Net Cash 34.17M
Net Cash Per Share $0.26
Equity (Book Value) 99.54M
Book Value Per Share 0.77
Working Capital 66.19M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $34.68 million and capital expenditures -$3.64 million, giving a free cash flow of $31.05 million.

Operating Cash Flow 34.68M
Capital Expenditures -3.64M
Free Cash Flow 31.05M
FCF Per Share $0.24
Full Cash Flow Statement

Margins

Gross margin is 67.82%, with operating and profit margins of 3.05% and 1.40%.

Gross Margin 67.82%
Operating Margin 3.05%
Pretax Margin 3.66%
Profit Margin 1.40%
EBITDA Margin 6.30%
EBIT Margin 3.05%
FCF Margin 15.40%

Dividends & Yields

Enfusion does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.09%
Shareholder Yield -0.09%
Earnings Yield 0.20%
FCF Yield 2.17%

Analyst Forecast

The average price target for Enfusion is $12.25, which is 10.36% higher than the current price. The consensus rating is "Buy".

Price Target $12.25
Price Target Difference 10.36%
Analyst Consensus Buy
Analyst Count 3
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Enfusion has an Altman Z-Score of 11.84 and a Piotroski F-Score of 6.

Altman Z-Score 11.84
Piotroski F-Score 6